Examining the formulation of emulsion electrospinning for improving the release of bioactive proteins from electrospun fibers
- 29 March 2013
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (3) , 674-684
Abstract
Emulsion electrospinning has been sought as a method to prepare fibrous materials/scaffolds for growth factor delivery. Emulsion conditions, specifically sonication and the addition of a surfactant, were evaluated to determine their effect on the release and bioactivity of proteins from electrospun scaffolds. Polycaprolactone (PCL) and poly(ethylene oxide) (PEO/PCL) blends were evaluated where PEO, a hydrophilic polymer, was shown to enhance the incorporation of proteins. Electrospun scaffolds prepared with the addition of the nonionic surfactant Span® 80 at a concentration greater than the critical micelle concentration followed by mild sonication (10% amplitude) released lysozyme, the model protein, with a higher level of bioactivity as compared with other surfactant and sonication conditions. These conditions were then used to prepare emulsions of platelet‐derived growth factor‐BB (PDGF‐BB) in PEO/PCL blends. Electrospun mats prepared by emulsions consisting of PDGF‐BB incorporated with Span® 80 and sonicated at 10% amplitude exhibited a controlled release of PDGF‐BB over 96 h as compared with a more rapid release from solutions that were not emulsified (Direct Addition) or emulsions that did not receive Span® 80 or sonication. Bioactive PDGF‐BB incorporated in electrospun scaffolds enhanced the osteogenic differentiation of human mesenchymal stem cells as evidenced by increased alkaline phosphatase activity, improved cell attachment and reorganized cytoskeletal filaments. The findings in this study provide improved methods for achieving controlled release of bioactive proteins from electrospun materials. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 674–684, 2014.Keywords
This publication has 62 references indexed in Scilit:
- Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun ScaffoldsPLOS ONE, 2012
- Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibersBiomaterials, 2011
- Controlled Release of PDGF-bb by Coaxial Electrospun Dextran/Poly(L-lactide-co-ε-caprolactone) Fibers with an Ultrafine Core/Shell StructureJournal of Biomaterials Science, Polymer Edition, 2010
- Recombinant human platelet‐derived growth factor BB (rhPDGF‐BB) and beta‐tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat modelJournal of Orthopaedic Research, 2009
- Osteogenic differentiation of human mesenchymal stem cells on poly(ethylene glycol)‐variant biomaterialsJournal of Biomedical Materials Research Part A, 2008
- Preparation, characterization, and encapsulation/release studies of a composite nanofiber mat electrospun from an emulsion containing poly(lactic-co-glycolic acid)Polymer, 2008
- Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineeringAdvanced Drug Delivery Reviews, 2007
- Preparation and Characterization of Novel Bone Scaffolds Based on Electrospun Polycaprolactone Fibers Filled with NanoparticlesMacromolecular Bioscience, 2005
- Bone engineering by controlled delivery of osteoinductive molecules and cellsExpert Opinion on Biological Therapy, 2004
- The effect of local delivery of PDGF‐BB on attachment of human periodontal ligament fibroblasts to periodontitis‐affected root surfaces – in vitroJournal of Clinical Periodontology, 2000